Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.9949
-0.0151-1.50%
At close: Jun 12, 5:00 PM EST
$1.00
0.00590.59%
After Hours: Jun 12, 7:24 PM EST
Cocrystal Pharma Inc Analyst Ratings
COCPNASDAQ
Cocrystal Pharma Analyst Ratings and Price Targets | NASDAQ:COCP | Benzinga
Cocrystal Pharma Inc has a consensus price target of $6 based on the ratings of 1 analysts. The high is $6 issued by HC Wainwright & Co. on June 20, 2025. The low is $6 issued by HC Wainwright & Co. on June 20, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on June 20, 2025, January 22, 2025, and August 22, 2024, respectively. With an average price target of $6.67 between HC Wainwright & Co., there's an implied 566.13% upside for Cocrystal Pharma Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Cocrystal Pharma
Loading calendar...
FAQ
What is the target price for Cocrystal Pharma (COCP) stock?
The latest price target for Cocrystal Pharma (NASDAQ:COCP) was reported by HC Wainwright & Co. on June 20, 2025. The analyst firm set a price target for $6.00 expecting COCP to rise to within 12 months (a possible 499.52% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cocrystal Pharma (COCP)?
The latest analyst rating for Cocrystal Pharma (NASDAQ:COCP) was provided by HC Wainwright & Co., and Cocrystal Pharma maintained their buy rating.
When was the last upgrade for Cocrystal Pharma (COCP)?
There is no last upgrade for Cocrystal Pharma
When was the last downgrade for Cocrystal Pharma (COCP)?
There is no last downgrade for Cocrystal Pharma.
When is the next analyst rating going to be posted or updated for Cocrystal Pharma (COCP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cocrystal Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cocrystal Pharma was filed on June 20, 2025 so you should expect the next rating to be made available sometime around June 20, 2026.
Is the Analyst Rating Cocrystal Pharma (COCP) correct?
While ratings are subjective and will change, the latest Cocrystal Pharma (COCP) rating was a maintained with a price target of $7.00 to $6.00. The current price Cocrystal Pharma (COCP) is trading at is $1.00, which is out of the analyst’s predicted range.
